Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 26, 2020British Journal of PharmacologyOpen Access

Restoration of HDAC2 and Nrf2 by andrographolide overcomes corticosteroid resistance in chronic obstructive pulmonary disease

View Full Paper
Ask AI
Bookmark
Share

Authors

WLWupeng LiaoNational University of SingaporeALAlbert Yick Hou LimTan Tock Seng HospitalWTW.S. Daniel TanAgency for Science, Technology and Research

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Liao et al. (2020) studied this question.

synapsesocial.com/papers/6a7378ec932cfe51ab71ae27https://doi.org/10.1111/bph.15080
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Burden of chronic obstructive pulmonary disease: Healthcare costs and beyond2014 · 303 citations
  2. 2Decreased histone deacetylase 2 impairs Nrf2 activation by oxidative stress2011 · 208 citations
  3. 3Animal Research: Reporting in vivo Experiments—The ARRIVE Guidelines2011 · 2,025 citations
  4. 4Regulation of NRF2, AP‐1 and NF‐κB by cigarette smoke exposure in three‐dimensional human bronchial epithelial cells2018 · 19 citations
  5. 5A Novel Antiinflammatory Role for Andrographolide in Asthma via Inhibition of the Nuclear Factor-κB Pathway2009 · 234 citations